Skip to content

Clinical observation on catgut embedding at acupoints for treatment of melasma

Clinical observation on catgut embedding at acupoints for treatment of melasma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004810
Enrollment
Unknown
Registered
2021-05-04
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
27 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 27 to 55 years; 2. Diagnosis of melasma according to the Diagnostic and Treatment Criteria of Melasma and Leukoderma of the Chinese Society of Integrated Traditional Chinese and Western Medicine; 3. Symptoms have been present for more than 1 month; 4. Patients with moderate to severe melasma, moderate is defined with a modified Melasma Area and Severity Index (mMASI) score of 5.8 to 7.9,and severe melasma is those with a mMASI > 8; 5. Patients who have not been treated for other melasma treatment in the past three months; 6. Avoid ultraviolet rays and oral contraceptives during treatment; 7. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing women; 2. Diseases such as cardiovascular, cerebrovascular, liver, kidney, blood system and mental disorders; 3. Patients with other facial pigmentation diseases, such as: zygomatic brown mole, melanosis, and pigmented actinic lichen planus, etc; 4. Coagulation disorders (such as hemophilia, etc.); 5. Have a history of allergy to catgut; 6. Participation in another clinical study in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Melasma Area and Severity Index(MASI);

Secondary

MeasureTime frame
Investigator's Global Assessment, IGA;The number of adverse reactions;The Dermatology Life Quality Index (DLQL);Melasma Area and Severity Index, MASI;

Countries

China

Contacts

Public ContactWang Guangan

The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

wagz123@163.com+86 15003859078

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026